Literature DB >> 27799651

Diagnosis of Visceral Leishmaniasis Using Peripheral Blood Microscopy in Ethiopia: A Prospective Phase-III Study of the Diagnostic Performance of Different Concentration Techniques Compared to Tissue Aspiration.

Ermias Diro1,2, Cedric P Yansouni3, Yegnasew Takele1, Bewketu Mengesha1, Lutgarde Lynen2, Asrat Hailu4, Johan van Griensven2, Marleen Boelaert2, Philippe Büscher2.   

Abstract

Visceral leishmaniasis (VL) is a fatal parasitic disease. Unfortunately, diagnosis of VL in east Africa currently relies on aspiration of tissue from the spleen or bone marrow, which is painful and potentially dangerous. We sought to determine whether peripheral blood could be used instead of invasive tissue aspirates to diagnose VL, using three parasite concentration techniques. Three hundred and one consecutive people suspected of having VL were recruited. Compared with microscopy of tissue aspirates, the diagnostic accuracy of peripheral blood microscopy was as follows: whole blood thin smear sensitivity 1.5% (95% confidence interval [CI] 0.0-8.3) and specificity 100% (95% CI 76.8-100); buffy-coat smear sensitivity 19.5% (95% CI 14.3-25.6) and specificity 98.9% (95% CI 94.1-100); peripheral blood mononuclear cell (PBMC) smear sensitivity 33.7% (95% CI 27.3-40.5) and specificity 95.7% (95% CI 89.6-98.6). Sensitivity of PBMC smears was significantly higher in human immunodeficiency virus (HIV)-coinfected patients (N = 48/301); two-sample test of proportions, P = 0.0097; sensitivity 55.9% (95% CI 37.9-72.8) and specificity 92.9% (95% CI 66.1-99.8), and correlated with the degree of parasite load in the tissue. Combining the results from smears of both PBMC and buffy coat yielded a sensitivity and specificity of 67.6% (95% CI 49.1-82.6) and 92.9% (95% CI 66.1-99.8), respectively, in HIV-coinfected patients. In this setting, VL could be ruled-in with peripheral blood microscopy in a substantial number of VL suspects and may reduce the number of tissue aspirations performed, particularly in HIV-coinfected patients. More sensitive and logistically feasible methods than light microscopy are needed to detect Leishmania donovani parasites present in blood. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Year:  2016        PMID: 27799651      PMCID: PMC5239691          DOI: 10.4269/ajtmh.16-0362

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

1.  Latent class analysis permits unbiased estimates of the validity of DAT for the diagnosis of visceral leishmaniasis.

Authors:  M Boelaert; S el Safi; E Goetghebeur; S Gomes-Pereira; D Le Ray; P Van der Stuyft
Journal:  Trop Med Int Health       Date:  1999-05       Impact factor: 2.622

2.  In defense of discrepant analysis.

Authors:  T A Green; C A Black; R E Johnson
Journal:  J Clin Epidemiol       Date:  2001-02       Impact factor: 6.437

3.  A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis.

Authors:  Marleen Boelaert; Suman Rijal; Sudhir Regmi; Rupa Singh; Balmansingh Karki; Diane Jacquet; François Chappuis; Lenea Campino; Philippe Desjeux; Dominique Le Ray; Shekhar Koirala; Patrick Van der Stuyft
Journal:  Am J Trop Med Hyg       Date:  2004-01       Impact factor: 2.345

4.  [Contribution of leukoconcentration in the diagnosis of Kala-azar in Tunisia].

Authors:  J Chemli; M Abroug; A Fathallah; S Abroug; M Ben Said; A Harbi
Journal:  Med Mal Infect       Date:  2006-07-26       Impact factor: 2.152

Review 5.  Visceral leishmaniasis.

Authors:  Johan van Griensven; Ermias Diro
Journal:  Infect Dis Clin North Am       Date:  2012-04-24       Impact factor: 5.982

6.  Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.

Authors:  Rachel ter Horst; Simon M Collin; Koert Ritmeijer; Adey Bogale; Robert N Davidson
Journal:  Clin Infect Dis       Date:  2008-06-01       Impact factor: 9.079

7.  Kala-azar outbreak in Libo Kemkem, Ethiopia: epidemiologic and parasitologic assessment.

Authors:  Jorge Alvar; Seife Bashaye; Daniel Argaw; Israel Cruz; Pilar Aparicio; Askal Kassa; Giannos Orfanos; Fernando Parreño; Olusegan Babaniyi; Nigussu Gudeta; Carmen Cañavate; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2007-08       Impact factor: 2.345

8.  A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis.

Authors:  Jane Cunningham; Epco Hasker; Pradeep Das; Sayda El Safi; Hiro Goto; Dinesh Mondal; Margaret Mbuchi; Maowia Mukhtar; Ana Rabello; Suman Rijal; Shyam Sundar; Monique Wasunna; Emily Adams; Joris Menten; Rosanna Peeling; Marleen Boelaert
Journal:  Clin Infect Dis       Date:  2012-08-31       Impact factor: 9.079

Review 9.  Complexities of assessing the disease burden attributable to leishmaniasis.

Authors:  Caryn Bern; James H Maguire; Jorge Alvar
Journal:  PLoS Negl Trop Dis       Date:  2008-10-29

Review 10.  Visceral Leishmaniasis and HIV coinfection in East Africa.

Authors:  Ermias Diro; Lutgarde Lynen; Koert Ritmeijer; Marleen Boelaert; Asrat Hailu; Johan van Griensven
Journal:  PLoS Negl Trop Dis       Date:  2014-06-26
View more
  4 in total

1.  Mediterranean visceral leishmaniasis : update on biological diagnosis.

Authors:  Emna Siala; Aida Bouratbine; Karim Aoun
Journal:  Tunis Med       Date:  2022 Janvier

2.  Development of a sandwich ELISA to detect Leishmania 40S ribosomal protein S12 antigen from blood samples of visceral leishmaniasis patients.

Authors:  Wen-Wei Zhang; Ayan Kumar Ghosh; Raodoh Mohamath; Jacqueline Whittle; Alessandro Picone; Patrick Lypaczewski; Momar Ndao; Randall F Howard; Pradeep Das; Steven G Reed; Greg Matlashewski
Journal:  BMC Infect Dis       Date:  2018-10-03       Impact factor: 3.090

3.  Antigen Detection in Urine for Noninvasive Diagnosis and Treatment Monitoring of Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients: An Exploratory Analysis from Ethiopia.

Authors:  Florian Vogt; Bewketu Mengesha; Helen Asmamaw; Tigist Mekonnen; Helina Fikre; Yegnasew Takele; Emebet Adem; Rezika Mohammed; Koert Ritmeijer; Wim Adriaensen; Yayehirad Melsew; Johan van Griensven; Ermias Diro
Journal:  Am J Trop Med Hyg       Date:  2018-10       Impact factor: 2.345

4.  Visceral leishmaniasis in acute myeloid leukemia revealed on peripheral blood smear.

Authors:  Maxime Moniot; Maxime Loyens; Charles Mary; Coralie L'Ollivier
Journal:  Clin Case Rep       Date:  2018-06-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.